High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)
作者： Yixuan Gong , Evelyn Yao , Ronglai Shen , Aviva Goel , Maria Arcila
DOI: 10.1371/JOURNAL.PONE.0007273
关键词:
摘要: Competing Interests: Stanley Frankel is employed by Hoffman La Roche and receives company stocks. Funding: The Joan Scarangello Foundation to Conquer Lung Cancer (YG WP). NIH/NCI (WP; R01 CA121210, P01 CA129243 K08 CA097980). Deutsche Krebshilfe (RTK; grant 107954). Fritz-Thyssen-Stiftung 10.08.2.175). NGFNplus-program of the German Ministry Science Education BMBF; 01GS08100). funders had no role in study design, data collection analysis, decision publish, or preparation manuscript.
mpg.de
harvard.edu
doaj.org
core.ac.uk 参考文章(24)
LH Sobin, WD Travis, TV Colby, B Corrin, Y Shimosato, E Brambilla, Histological Typing of Lung and Pleural Tumours ,(1999)
D. D. Karp, L. G. Paz-Ares, L. J. Blakely, H. Kreisman, P. D. Eisenberg, R. B. Cohen, L. Garland, C. J. Langer, C. L. Melvin, A. Gualberto, Efficacy of the anti-insulin like growth factor I receptor (IGF-IR) antibody CP-751871 in combination with paclitaxel and carboplatin as first-line treatment for advanced non-small cell lung cancer (NSCLC) Journal of Clinical Oncology. ,vol. 25, pp. 7506- 7506 ,(2007) , 10.1200/JCO.2007.25.18_SUPPL.7506
A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, C. Smigal, M. J. Thun, Cancer statistics, 2006. CA: A Cancer Journal for Clinicians. ,vol. 56, pp. 106- 130 ,(2006) , 10.3322/CANJCLIN.56.2.106
D Yee, Targeting insulin-like growth factor pathways. British Journal of Cancer. ,vol. 94, pp. 465- 468 ,(2006) , 10.1038/SJ.BJC.6602963
T. E. Adams, V. C. Epa, T. P. J. Garrett, C. W. Ward*, Structure and function of the type 1 insulin-like growth factor receptor. Cellular and Molecular Life Sciences. ,vol. 57, pp. 1050- 1093 ,(2000) , 10.1007/PL00000744
M. Derrane, A breath of fresh air: lung cancer survival shows some improvement. Journal of the National Cancer Institute. ,vol. 90, pp. 1770- 1771 ,(1998) , 10.1093/JNCI/90.23.1770
Rafal Dziadziuszko, Daniel T. Merrick, Barbara Szostakiewicz, Amelia Szymanowska, Witold Rzyman, Ewa Jassem, Kazimierz Jaskiewicz, Jacek Jassem, Paul A. Bunn, Fred R. Hirsch, P2-073: High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically treated patients with non-small cell lung cancer (NSCLC) Journal of Thoracic Oncology. ,vol. 2, pp. S519- ,(2007) , 10.1097/01.JTO.0000283537.72976.6C
J. A. Engelman, P. A. Janne, C. Mermel, J. Pearlberg, T. Mukohara, C. Fleet, K. Cichowski, B. E. Johnson, L. C. Cantley, ErbB-3 mediates phosphoinositide 3-kinase activity in gefitinib-sensitive non-small cell lung cancer cell lines. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 102, pp. 3788- 3793 ,(2005) , 10.1073/PNAS.0409773102
M. G. Myers, J. M. Backer, X. J. Sun, S. Shoelson, P. Hu, J. Schlessinger, M. Yoakim, B. Schaffhausen, M. F. White, IRS-1 activates phosphatidylinositol 3'-kinase by associating with src homology 2 domains of p85 Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 10350- 10354 ,(1992) , 10.1073/PNAS.89.21.10350
Keren Paz, Yaron Hadari, Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer Combinatorial Chemistry & High Throughput Screening. ,vol. 11, pp. 62- 69 ,(2008) , 10.2174/138620708783398313